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Shc proteins play a role in energy metabolism through interaction with the insulin receptor. The aim of
this study was to determine whether Shc proteins inﬂuence liver glycolysis and gluconeogenesis under
both fed and fasted states. Decreased glycolytic and increased gluconeogenic and transamination enzyme
activities were observed in ShcKO versus WT mice. Levels of key regulatory metabolites, such as fructose-
2,6-bisphosphate, matched the activity of metabolic pathways. Protein levels of glycolytic and gluco-
neogenic enzymes were not different. pAMPK protein levels increased with fasting and were higher in
ShcKO versus WT mice. Therefore, Shc proteins play a role in shifting the metabolism from glucose
oxidation to gluconeogenesis and lipid catabolism and should be considered as regulators of fuel se-
lection. Fuel selection and utilization could play a critical role in healthy aging. Characterization of
metabolic events in ShcKO mice would help to elucidate how metabolism is inﬂuenced by these proteins.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Three adaptor proteins, p66Shc, p46Shc and p52Shc, are encoded
by the Shc locus in mammals and are involved in signal transmis-
sion from growth factor receptors [1]. The three isoforms are the
result of alternative splicing or translation initiation of the same
RNA [1,2]. Additionally, an independent p66Shc promotor has also
been described [3]. Previous reports have implicated Shc proteins in
insulin/IGF-1 and receptor tyrosine kinase signaling [1,4], suggest-
ing that these proteins may play a role in energy metabolism. Initial
studies investigating the inﬂuence of Shc proteins on whole animalr B.V. This is an open access article
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Aging, 8001 Redwood Blvd,energy metabolism focused on the p66Shc isoform using the
p66Shc KO mouse [5,6]. However, while these mice lack p66Shc, it
has been recently shown that they also have decreased levels of
p52Shc in all tissues and decreased levels of p46Shc in liver, skeletal
muscle and heart [7]. Thus, these mice (referred to as ShcKO
hereafter) provide a model of overall decreases in Shc proteins in
multiple tissues. The ﬁrst evidence that Shc proteins may have an
important inﬂuence on whole animal energy metabolism came
from a study showing that ShcKO mice were resistant to weight
gain on a high fat diet [5]. Weight gain was also decreased in leptin
deﬁcient ShcKO Ob/Ob mice compared to wild-type Ob/Ob animals
[6]. Insulin sensitivity and glucose tolerance were also increased in
ShcKO mice [6,7], providing further evidence that Shc proteins
modulate whole animal energy metabolism. However, relatively
little is known about the inﬂuence of Shc proteins on major cellular
metabolic pathways. It has recently been shown that changes in
enzyme activities and regulatory metabolite levels in ShcKO mice
indicate a decreased capacity for glycolysis in skeletal muscle from
these animals compared to wild-type controls under both fed and
fasting conditions [8]. The activities of fatty acid β-oxidation en-
zymes in liver and skeletal muscle were also increased in ShcKO
compared to wild-type mice in the fasted state, and the activities of
ketogenic enzymes were increased in liver from ShcKO versus wild-
type mice [9]. Moreover, we have reported recently that the β-
oxidation enzyme 3-ketoacyl-CoA thiolase was directly inﬂuenced
by p46Shc through binding that resulted in decreased activity andunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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enzyme [10]. The results of our current studies are consistent with
the idea that Shc proteins may play a role in regulating substrate
oxidation.
Liver plays a central role in glucose metabolism, and serves as a
major site for glycolysis under fed conditions and functions as the
primary site for gluconeogenesis under fasting conditions [11]. In
glycolysis, three enzymes, glucokinase, phosphofructokinase-1
and pyruvate kinase, play key roles in its regulation [12], while
four enzymes, namely, pyruvate carboxylase, phosphoenolpyr-
uvate carboxykinase, fructose-1,6-bisphosphatase and glucose
6-phosphatase, are involved in the regulation of gluconeogenesis
[13]. Additionally, PDH is another key regulatory point by virtue of
its position, linking glycolysis to Krebs cycle. While it has recently
been shown that the glycolytic capacity was decreased in skeletal
muscle from ShcKO mice [8], little is known about the inﬂuence of
Shc proteins on glycolysis or gluconeogenesis in liver.
The aim of the current study was to establish the role of Shc
proteins in the regulation of glycolytic and gluconeogenic enzyme
activities in the livers of WT and ShcKO mice under both fed and
fasted states. The impact of Shc proteins on various metabolites
and other regulatory parameters that exert inﬂuence on these
pathways was also investigated.2. Materials and methods
2.1. Materials and antibodies
General laboratory chemicals and reagents were purchased from
Sigma-Aldrich (St. Louis, MO), except bovine serum albumin (MP
Biochemicals, Santa Ana, CA), Bio-Rad protein assay dye (BioRad,
Hercules, CA), p-(p-aminophenylazo)-benzene sulphonic acid (Alfa
Aesar, Ward Hill, MA) and NAD, NADH and ATP (Roche Diagnostics,
Indianapolis, IN). Auxiliary enzymes used in the measurement of
glycolytic, gluconeogenic and transamination enzyme activities, as
well as in metabolite determinations were from Sigma-Aldrich (St.
Louis, MO) or Roche Diagnostics (Indianapolis, IN). Primary anti-
bodies used in this work were rabbit anti-GK antibody (Life Span
Biosciences, Atlanta, GA), goat anti-PFK1 (GenWay Biotech, San Diego,
CA), mouse anti-AMPK, rabbit anti-pAMPK, rabbit anti-FOXO1 and
rabbit anti-Shc (Cell Signaling, Danvers, MA), mouse anti-tubulin
(Sigma Aldrich, St Louis, MO), mouse anti-PDH (Mito Sciences, Eu-
gene, OR), goat anti-GKRP, rabbit anti-PEPCK, rabbit anti-FBPase and
rabbit anti-pPDH (Novus Biologicals, Littleton, CO), and rabbit anti-
PDK4 antibody (kindly provided by Dr. Pengfei Wu, Department of
Medicine, Indiana University School of Medicine, Indianapolis, IN).
2.2. Animals
The ShcKO mice were provided by Dr. Pier Giuseppe Pelicci
(Department of Experimental Oncology, European Institute of
Oncology, Milan, Italy), and used for the establishment of a
breeding colony at UC Davis, as previously described [8]. Male
wild-type and ShcKO mice used in all experiments were housed in
a controlled animal facility at 22–24 °C and 40–60% humidity, with
a 12 h light: dark cycle. All mice had free access to food (LM485,
Teklad, Madison, WI) and water. At 3 months of age, the mice were
randomly divided into two groups: fed and fasted. For the fasted
group, mice were deprived of food for 16 h and then sacriﬁced.
Mice in the fed group were deprived of food for 16 h followed by
3 h of feeding then sacriﬁced. All animal care and use protocols
were approved by the UC Davis Institutional Animal Care and Use
Committee (IACUC) and are in accordance with the National In-
stitutes of Health (NIH) guidelines for the Care and Use of La-
boratory Animals.2.3. Tissue harvesting and preparation
Mice were sacriﬁced by cervical dislocation between 9–10am
and weighed. Livers were rapidly removed, weighed immediately
and frozen in liquid nitrogen. Frozen livers were then powdered in
a porcelain mortar and pestle maintained under liquid nitrogen.
All tissue powders were stored under liquid nitrogen.
2.4. Gluconeogenic and glycolytic enzyme assays
The activities of gluconeogenic enzymes pyruvate carboxylase
(PC, EC 6.4.1.1), phosphoenolpyruvate carboxykinase (PEPCK, EC
4.1.1.32), fructose-1,6-bisphosphatase (FBPase, EC 3.1.3.11) and
glucose-6-phosphatase (G6Pase, EC 3.1.3.9) were measured in li-
ver, as previously described [14]. The activities of the glycolytic
enzymes glucokinase (GK, EC 2.7.1.1), phosphofructokinase-1
(PFK1, EC 2.7.1.11) and pyruvate kinase (PK, EC 2.7.1.40) were also
measured in liver as previously described [15]. All assays were
performed using a Perkin Elmer Lambda 25 UV/Vis spectro-
photometer equipped with a Peltier heating control system and
9 cell changer (Perkin Elmer, Shelton, CT). Reactions were followed
at 340 nm (ε¼6.22 mM1.cm1) for GK, PFK1, PK, FBPase and
PEPCK, 412 nm (ε¼13.6 mM1.cm1) for PC and 510 nm (ε¼
6.66 mM1.cm1) for G6Pase. All enzyme activities were ex-
pressed as μmol/min/mg protein, and presented as mean7SEM
determined from at least six animals.2.5. Pyruvate dehydrogenase complex assay
The activity of pyruvate dehydrogenase complex (PDH, EC
1.2.4.1þEC 2.3.1.12þEC 1.8.1.4) was assayed spectrophotometrically
at 460 nm (ε¼7.11 mM1cm1), by coupling to the activity of ar-
ylamine acetyltransferase (AAT, EC 2.3.1.5) and the dye p-(p-ami-
nophenylazo)-benzene sulphonic acid (AABS), as previously
described [8]. Activities were expressed as μmol/min/mg protein
and presented as mean7SEM determined from at least six animals.
2.6. Transamination enzyme assays
Alanine transaminase (ALA, EC 2.6.1.2), aspartate transaminase
(ASP, EC 2.6.1.1), tryptophan transaminase (TRT, EC 2.6.1.27) and
tyrosine transaminase (TYT, EC 2.6.1.5) were assayed as previously
described [14]. The assays were performed spectrophotometrically,
and the reactions were followed at 340 nm (ε¼6.22 mM1.cm1)
for ALA and ASP, 328 nm (ε¼14 mM1.cm1) for TRT and 310 nm
(ε¼9.85 mM1.cm1) for TYT. Activities were expressed as μmol/
min/mg protein and presented as mean7SEM determined from at
least six animals.2.7. Glucose and glycogen levels
Liver glucose and glycogen levels were determined based on
measuring both free glucose levels and glucose resulting from
glycogen hydrolysis as previously described [8]. Liver powders
were homogenized in 6% (w/v) perchloric acid and a small portion
was taken for glycogen hydrolysis and the remainder used for
glucose determination, as described in the indicated method. Total
and free glucose levels were determined at 340 nm (ε¼
6.22 mM1cm1). Subtraction of free glucose from the total glu-
cose gave glucose levels resulting from glycogen hydrolysis, hence
glycogen levels. Concentrations were presented as mean7SEM
determined from at least six animals and values expressed as
μmol/g wet weight.
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Frozen liver powders were homogenized in 6% (w/v) perchloric
acid, except for F2,6BP which was homogenized in 0.05 M NaOH,
according to the indicated methods. The metabolites G6P, F6P,
F1,6BP, F2,6BP, PEP, Pyr, Lac and ketone bodies were measured as
previously described [15]. Acetyl-Co and CoA [14], fructose and
fructose-1-phosphate [16], as well as malate and α-ketoglutarate
[17] were also measured as indicated. All values were expressed as
μmol/g wet weight, except for fructose-2,6-bisphospahte which
was expressed as nmol/g wet weight. All data were presented as
mean7SEM from at least six animals.
2.9. Electrophoresis and western blotting
Total proteins were prepared using lysis buffer (Cell Signaling
Technologies, Danvers, MA) and resolved by SDS–PAGE electro-
phoresis. Proteins were transferred to nitrocellulose membrane
using the iBlot system (Life Technologies, Calrsbad, CA) and
blocked with Odyssey Blocking Buffer (Li-Cor Biosciences, Lincoln,
NE). The membranes were probed with the following primary
antibodies, using the indicated dilution: rabbit anti-GK (1/500),
goat anti-PFK (1/1000), anti-PEPCK (1/1000), anti FBPase (1/500),
rabbit anti-pAMPK (1/500), mouse anti-AMPK (1/1000), rabbit
anti-FOXO1 (1/500), mouse anti-tubulin (1/5000), rabbit anti-
PDK4 (1/500), mouse anti-PDH (1/1000), rabbit anti-pPDH (1/
500), and goat anti-GKRP (1/2000). This was followed by treat-
ment with infrared IR-dye 700CW and/or 800CW-labeled sec-
ondary antibodies (Li-Cor Biosciences, Lincoln, NE). The blots were
then scanned and protein levels quantiﬁed using Li-Cor Odyssey
infrared imaging instrument and Odyssey 2.1 software.
2.10. Protein assays
Protein concentrations were determined using the Bio-Rad
protein assay kit (Bio-Rad Laboratories, Hercules, CA), with BSA as
the standard.
2.11. Statistical analysis
Differences between genotypes and dietary regimens were
evaluated with a two-way ANOVA with genotype and dietary re-
gimen as main effects and including the interaction between these
factors. All analyses were conducted in R version 3.02. Where the
overall ANOVA was signiﬁcant, we identiﬁed genotypes and diet-
ary regimens that differed signiﬁcantly using Tukey's multiple
comparison procedure and maintained the family-wise error rate
at 0.05.3. Results
3.1. Activities of glycolytic enzymes and PDH complex
The enzymes GK, PFK1 and PK were assayed from livers of WT
and ShcKO mice (Fig. 1A–C, respectively). All three enzymes
showed lower activities (Po0.05) in the ShcKO mice under both
fed and fasting states when compared to WT mice. Moreover,
under the fasting state, activities of all three enzymes in both WT
and ShcKO mice were lower (Po0.05) than activities under the
fed state. PDH complex activity (Fig. 1D) was lower (Po0.05) in
the ShcKO versus WT mice under the fed state. Fasting resulted in
decreased activities (Po0.05) in both WT and ShcKO mice, how-
ever, the fasted ShcKO mice displayed higher activities (Po0.05)
than the fasted WT mice.3.2. Activities of gluconeogenic enzymes
The activities of the four enzymes were measured from livers of
WT and ShcKO mice (Fig. 1). PC and FBPase activities (Fig. 1E and
G) were not different between WT and ShcKO mice in the fed or
fasted states. PEPCK activity (Fig. 1F) in the ShcKO mice showed a
trend towards an increase (P¼0.089) in the fed state compared to
WT, while in the fasted state it was higher (Po0.05) than the WT.
The activity of G6Pase (Fig. 1H) was similar to the PEPCK activity
patterns, with ShcKO mice showing a trend towards an increase
(P¼0.076) in the fed state and a higher activity (Po0.05) in the
fasted state when compared to their WT counterparts. For all four
enzymes, under fasting conditions, activities in both WT and
ShcKO mice were higher (Po0.05) than fed mice.
3.3. Ratios of gluconeogenic to glycolytic enzymes
The ratios of gluconeogenic to glycolytic enzyme activities were
determined as indicators of increased gluconeogenesis. The ratios
PEPCK/PK (Fig. 1J), FBPase/PFK1 (Fig. 1K) and G6Pase/GK (Fig. 1L)
were higher (Po0.05) in the fasted state indicating increased
gluconeogenesis, and were higher (Po0.05) in the ShcKO versus
WT mice under both fed and fasting states. However, the ratio of
PC/PDH (Fig. 1I) was higher (Po0.05) in WT and ShcKO mice in
the fasted versus fed state while in the fasted state this ratio was
lower (Po0.05) in the ShcKO versus WT consistent with higher
PDH activity in the fasted ShcKO animals.
3.4. Activities of transaminase enzymes
Several transaminase enzyme activities were also determined
(Fig. 2). All transaminase enzyme activities were increased
(Po0.05) in the fasted versus fed state for both WT and ShcKO
mice. There were no differences in ALT and AST activities (Fig. 2A
and B) between WT and ShcKO mice in either the fed or fasted
states. In contrast, TRT activity (Fig. 2C) in ShcKO mice showed a
trend towards an increase (P¼0.07) in the fed state and was in-
creased (Po0.05) in the fasted state when compared to WT mice.
TYT activity (Fig. 2D) was also increased (Po0.05) in fasted ShcKO
compared to WT mice, while there were no differences between
the genotypes in the fed state.
3.5. Levels of glucose and glycogen in liver
Hepatic levels of glucose and glycogen were measured in the
WT and ShcKO mice (Fig. 3). Glycogen (Fig. 3A) and glucose
(Fig. 3B) levels were lower (Po0.05) in the fasted versus fed state
for both genotypes. Glycogen levels (Fig. 3A) were not different
between WT and ShcKO mice in the fed or fasted state. No dif-
ferences in glucose levels (Fig. 3B) were observed between WT and
ShcKO mice in the fed state, while in the fasted state the ShcKO
mice had lower (Po0.05) glucose levels compared to WT.
3.6. Liver metabolite levels
The levels of several metabolites of the glycolytic/gluconeo-
genic pathways from liver were measured (Fig. 3). When com-
paring ShcKO and WT animals, the ShcKO mice displayed lower
(Po0.05) G6P, F6P and F1,6 BP levels versus WT mice in both fed
and fasted states (Fig. 3C, D and 3E, respectively). The ratio of F6P/
F1,6BP (Fig. 3F), an indicator of PFK1 inhibition, was higher
(Po0.05) in the ShcKO versus WT mice in both fed and fasted
states. Pyruvate levels (Fig. 3G) in the ShcKO versus WT mice were
lower (Po0.05) in the fed state but higher (Po0.05) in the fasted
state, while lactate levels (Fig. 3H) were higher (Po0.05) in ShcKO
versus WT mice in both fed and fasted states. The Lactate/Pyruvate
Fig. 1. Glycolytic and gluconeogenic enzyme activities and their ratios in livers from ShcKO and WT mice under fed or fasted states. All values are mean7SEM (n ¼6) and
presented as μmol/min/mg protein. The following comparisons were made: within a genotype, fed versus fasted; across genotypes, fed versus fed and fasted versus fasted.
Bars that do not share a common symbol differ signiﬁcantly (Po0.05). The symbol () is used to indicate a trend towards an increase or a decrease (Po0.10) when the
difference is not signiﬁcant.
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Fig. 2. The activities of transamination enzymes in the livers from ShcKO and WT mice under fed or fasted states. All values are mean7SEM (n¼6) and presented as μmol/
min/mg protein. The following comparisons were made: within a genotype, fed versus fasted; across genotypes, fed versus fed and fasted versus fasted. Bars that do not
share a common symbol differ signiﬁcantly (Po0.05). The symbol () is used to indicate a trend towards an increase or a decrease (Po0.10) when the difference is not
signiﬁcant.
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under both fed and fasted states. PEP (Fig. 3J) and malate (Fig. 3K)
showed similar patterns and were the only metabolites that in-
creased (Po0.05) with fasting in both genotypes (Fig. 3J and L),
and were higher (Po0.05) in ShcKO versus WT mice. Citrate levels
(Fig. 3L) were lower (Po0.05) in the ShcKO versus WT mice under
both fed and fasted states, but showed a trend toward a decrease
with fasting in both the WT (Po0.065) and ShcKO (Po0.089)
mice. α-Ketoglutarate levels (Fig. 3M) were similar for WT and
ShcKO mice in the fed state but were lower (Po0.05) in the fasted
ShcKO, and the ratio of malate/α-ketoglutarate (Fig. 3N) was
higher (Po0.05) in ShcKO animals in the fasted state.
3.7. Levels of ketone bodies
Total ketone body concentrations in the livers (Fig. 3O) were
higher (Po0.05) in ShcKO versus WT mice in both fed and fasted
states. Fasting increased (Po0.05) the levels even further for bothShcKO and WT mice. The β-hydroxybutyrate to acetoacetate ratio
(Fig. 3P), an indicator of mitochondrial redox state, was also higher
(Po0.05) in the ShcKO versus WT mice, in both fed and fasted
states. Fasting increased (Po0.05) the ratios in both genotypes.
3.8. Levels of acetyl-CoA and CoA in liver
Acetyl-CoA levels (Fig. 4A) were higher (Po0.05) in the ShcKO
versus WT mice under both fed and fasted states. Fasting increased
acetyl-CoA levels, with both WT and ShcKO mice displaying higher
(Po0.05) levels versus their fed counterparts. No differences in
the CoA levels (Fig. 4B) were observed between WT and ShcKO
mice, under both fed and fasted states, but the levels were higher
(Po0.05) under fasted versus fed state in both WT and ShcKO
mice. The ratio of acetyl-CoA/CoA (Fig. 4C) showed similar patterns
to that of the acetyl-CoA, with higher ratios in fed and fasted
ShcKO versus WT mice.
Fig. 3. Levels of glycolytic metabolites, total ketone bodies and other metabolites in the livers from ShcKO andWT mice under fed or fasted states. All values are mean7SEM
(n¼6) and presented as μmol/g wet weight. The following comparisons were made: within a genotype, fed versus fasted; across genotypes, fed versus fed and fasted versus
fasted. Bars that do not share a common symbol differ signiﬁcantly (Po0.05). The symbol () is used to indicate a trend towards an increase or a decrease (Po0.10) when
the difference is not signiﬁcant.
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Fig. 4. Levels of acetyl-CoA, CoA, F2,6BP, fructose and F1P in the livers from ShcKO and WT mice under fed or fasted states. All values are mean7SEM (n¼6) and presented
as μmol/g wet weight, except for F2,6BP which was presented as nmol/g wet weight. The following comparisons were made: within a genotype, fed versus fasted; across
genotypes, fed versus fed and fasted versus fasted. Bars that do not share a common symbol differ signiﬁcantly (Po0.05). Data presented as mean7SEM (n¼6). The symbol
() is used to indicate a trend towards an increase or a decrease (Po0.10) when the difference is not signiﬁcant.
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phosphate in liver
Liver F2,6BP levels (Fig. 4D) were lower (Po0.05) in the ShcKO
versus WT mice under both fed and fasted states. Moreover, in the
fasted state, both WT and ShcKO mice showed decreased levels
(Po0.05) compared to the fed mice. Fructose levels (Fig. 4E)
showed no differences between WT and ShcKO mice under the fed
state, but under the fasted state, a trend towards a decrease
(P¼0.06) in the ShcKO versus WT mice was observed. Fasting
decreased (Po0.05) fructose levels in both WT and ShcKO mice
when compared to the corresponding fed mice. In the case of F1P(Fig. 4F), no differences in the levels were observed between WT
and ShcKO mice in the fed state, however, in the fasted state, the
levels in ShcKO were lower (Po0.05) than the WT.
3.10. Protein Levels of the glycolytic and gluconeogenic enzymes, and
GKRP in liver
The protein levels were determined by western blotting (Fig. 5).
GK, PFK-1, GKRP, PEPCK and FBPase did not show any differences
between WT and ShcKO mice in the fed or fasted states (Fig. 5).
However, with GKRP (Fig. 5C), lower levels (Po0.05) were observed
in the fasted versus fed states in both the WT and ShcKO mice.
Fig. 5. Protein levels of GK, PFK1, GKRP, PEPCK and FBPase in the livers from ShcKO and WT mice under fed or fasted states. Western blotting was performed as described. All
values are mean7SEM (n¼6). The following comparisons were made: within a genotype, fed versus fasted; across genotypes, fed versus fed and fasted versus fasted. Bars
that do not share a common symbol differ signiﬁcantly (Po0.05).
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Western blotting of liver samples indicated that there were no
differences in the levels of PDH between WT and ShcKO in the fedor fasted states (Fig. 6B). The levels of liver pPDH (Fig. 6C) were
also not different between WT and ShcKO mice in the fed state,
however, the levels were increased (Po0.05) in the fasted state,
with the WT levels being higher (Po0.05) than the ShcKO. In the
Fig. 6. Protein levels of PDH, pPDH and PDK4 in the livers from ShcKO and WT mice under fed or fasted states. Western blotting was performed as described. The activity of
PDH (A) is presented here for comparison. All values are means7SEM. The following comparisons were made: within a genotype, fed versus fasted; across genotypes, fed
versus fed and fasted versus fasted. Bars that do not share a common symbol differ signiﬁcantly (Po0.05).
K. Hagopian et al. / Biochemistry and Biophysics Reports 7 (2016) 273–286 281case of PDK4 (Fig. 6D), higher levels (Po0.05) were observed in
the ShcKO versus WT in the fed state. Fasting increased the levels
of PDK4 (Po0.05) in WT and ShcKO mice, but the fasted ShcKO
mice showed levels that were lower (Po0.05) than the fasted WT
mice. This pattern of PDK4 corresponds with the observed PDH
activities (Fig. 6A). The results also showed that the pPDH/PDH
ratio (Fig. 6E) was unchanged between the fed WT and ShcKOmice but increased with fasting, with the ratio being higher
(Po0.01) in the WT versus ShcKO mice.
3.12. Protein Levels of AMPK, pAMPK and FOXO1
The protein levels of AMPK, pAMPK and FOXO1 were de-
termined by western blotting (Fig. 7). Levels of AMPK remained
Fig. 7. Protein levels of pAMPK, FOXO1 and Shc proteins in the livers from ShcKO and WT mice under fed or fasted states. Western blotting was performed as described. All
values are means7SEM. The following comparisons were made: within a genotype, fed versus fasted; across genotypes, fed versus fed and fasted versus fasted. Bars that do
not share a common symbol differ signiﬁcantly (Po0.05).
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but fasting increased (Po0.05) pAMPK levels (Fig. 7A) in both WT
and ShcKO mice when compared to fed mice, with ShcKO mice
having higher levels (Po0.05) than the WT. However, there were
no differences between the fed WT and ShcKO mice. Fasting in-
creased (Po0.05) FOXO1 levels (Fig. 7B) in both the ShcKO andWT mice compared to the fed, however, there were no differences
between the two genotypes in the fed or fasted states.
3.13. Levels of Shc proteins in liver
Liver p66Shc, p52Shc and p46Shc proteins were determined by
western blotting (Fig. 7C). The levels of p66Shc were undetectable
K. Hagopian et al. / Biochemistry and Biophysics Reports 7 (2016) 273–286 283in the ShcKO mice in both the fed and fasted states. However, the
levels of p52Shc and p46Shc were also lower (Po0.05) in the
ShcKO versus WT mice in both the fed and fasted states.4. Discussion
The results of the present study show a decrease in capacity for
glycolysis and an increase in capacity for gluconeogenesis in
ShcKO versus WT mice based on the activity of key regulatory
enzymes in these pathways. We have previously reported in ske-
letal muscle that capacity for glycolysis was decreased in ShcKO
mice [8], while β-oxidation enzyme activities were increased [9].
These results are consistent with the idea that Shc proteins play a
role in fuel selection. The present study shows that Shc-related
shifts in the activities of enzymes in major metabolic pathways are
not limited to skeletal muscle but also occur in liver. In liver, when
glucose availability becomes limiting, the activity of the glycolytic
pathway is suppressed to prevent the oxidation of the available
glucose and preserve it for other tissues, such as the brain. This
leads to the activation of the gluconeogenic pathway, which is
accompanied by increased transamination so that amino acids
could be utilized as sources of energy. Decreased Shc levels alter
enzyme activities in a manner which creates an environment
which would promote the transition from glycolysis to gluconeo-
genesis when supply of glucose is restricted. The integration of theFig. 8. The integration of glycolytic, gluconeogenic, PDH, transamination and ketogenesis
or down black arrows indicate increased or decreased activities, respectively, of a giv
Thickness of the up or down black arrows indicates the magnitude of the increased o
comparison is made between the fasted WT and ShcKO mice. The thickness of the path
under the speciﬁc nutritional state.glycolytic, gluconeogenic, PDH, transamination and ketogenesis
pathways is presented in Fig. 8.
The mechanisms through which Shc proteins inﬂuence the ac-
tivities of glycolytic and gluconeogenic enzymes are not known.
However, similar to skeletal muscle [8], Shc-related changes in en-
zyme activity do not appear to be due to alterations in gene ex-
pression since there were no differences in the protein levels of
glycolytic or gluconeogenic enzymes between ShcKO and WT mice.
We have recently reported that the activity of thiolase was decreased
through direct binding with p46Shc [10] and it is possible that the
activities of other enzymes could be altered through binding with Shc
proteins. Additional studies are needed to determine if Shc proteins
bind and directly inﬂuence the activities of any enzymes in the gly-
colysis or gluconeogenesis pathways. It is also possible that the Shc-
related changes in enzyme activity are due to post-translational
modiﬁcations, since glycolytic and gluconeogenic enzyme are regu-
lated by phosphorylation [18,19] and acetylation [20,21]. In the pre-
sent study, markers of redox state consistently indicated that the
cytosolic (Lac/Pyr) and mitochondrial (β-HB/Ace) compartments
were more reduced in the ShcKO compared to wild-type mice. Future
studies are needed to determine if the increased NADH/NAD ratio
expected under these conditions would alter sirtuin activity and
enzyme acetylation in a manner which could contribute to the en-
zyme activity changes observed in the ShcKO mice.
To determine if the Shc-related changes in the activities of the
enzymes at the major control points in glycolysis and gluconeogenesispathways in the livers of fastedWT (left panel) and fasted KO (right panel) mice. Up
en enzyme/metabolite ratio when compared with their corresponding fed state.
r decreased activity of a given enzyme/metabolite ratio in the fasted state when
way arrows indicates the increased or decreased capacity of the speciﬁc pathway
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metabolites were measured and enzyme activity ratios were de-
termined. Changes in metabolite levels in the ShcKO compared to WT
mice were consistent with a decrease in glycolysis and increase in
gluconeogenesis in the ShcKO animals. In particular, the F6P/F1,6BP
ratio was signiﬁcantly increased in ShcKO mice under both fed and
fasted conditions indicating decreased activity of PFK1, a major reg-
ulator of glycolysis [22]. Also, the higher enzyme activity ratios of
PEPCK/PK, FBPase/PFK1 and G6Pase/GK in liver from ShcKO compared
to WT mice all provide an indication of increased gluconeogenesis
[23]. Thus, metabolite levels and enzyme activity ratios indicate that
glycolysis is decreased and gluconeogenesis increased in the ShcKO
animals.
Metabolites may also inﬂuence metabolism by acting as in-
hibitors or activators of enzymes. The decreases in GK, PFK1 and
PK activities and increases in PEPCK and G6Pase activities in
ShcKO liver would likely be ampliﬁed in vivo by the changes in
regulatory metabolites that occurred in these mice. GK is inhibited
when bound to GKRP and F1P removes this inhibition by inducing
dissociation of GKRP from GK [24]. The decrease in F1P levels
during fasting in ShcKO vs WT liver would thus be ineffective at
dissociating GKRP from GK and decrease GK activity in these an-
imals. GK has also been reported to be inhibited by lactate [25] and
the increased lactate levels under both fed and fasted states would
also be expected to contribute to decreased GK activity in ShcKO
livers. GK has also been reported to be inhibited by long-chain
fatty acyl-CoAs [26,27], and we have previously reported that β-
oxidation is stimulated in p66ShcKO mice and total ketone body
levels are increased in these animals [9] supporting the idea that
GK would be inhibited due to fatty acid mobilization. Thus, the
metabolite changes which occur with ShcKO are consistent with a
decrease in GK activity.
PFK1 is a major regulatory site that controls glycolysis by a
complex allosteric regulation [22]. PFK1 is activated by the meta-
bolite F2,6BP which is produced and degraded by the bifunctional
enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
[28,29]. The decrease in F2,6BP levels in liver under fed and fasted
conditions in ShcKO versus WT mice are consistent with low PFK1
activity in the ShcKO animals. PFK1 is also inhibited by lactate
[25,30], and the increased levels of lactate in the ShcKO livers
would be expected to contribute to its inhibition. Taken together
the low F2,6BP and high lactate levels in ShcKO compared to WT
liver would be expected to create an environment which inhibits
PFK1 activity.
Liver PK is regulated allosterically by F1,6BP, the product of PFK1,
in a feed-forward activation mechanism [18,31]. Under the fasted
state, with prevailing gluconeogenesis, control of PK activity is critical
for preventing the pathway from proceeding towards pyruvate pro-
duction. Hence, the decline in the level of F1,6BP plays an important
role in controlling PK activity and allowing gluconeogenesis to pro-
ceed. Higher levels of acetyl-CoA as observed in ShcKO liver are also
inhibitory to PK activity and are in agreement with previous reports
that the activities of enzymes of β-oxidation and ketone body me-
tabolism are increased in skeletal muscle and liver from ShcKO
compared toWTmice [9,32]. These results are consistent with ShcKO
playing a role in shifting metabolism away from glucose catabolism
toward fatty acid oxidation and gluconeogenesis.
PDH plays a pivotal role in metabolism by linking the glycolytic
pathway to Krebs cycle, and its regulation is controlled not only by
phosphorylation/dephosphorylation but also by changes in meta-
bolite levels [33–35]. The PDH activity pattern in liver was similar
to those previously reported in ShcKO and WT skeletal muscle [8]
where it was lower in ShcKO versus WT muscle in the fed state
while the decrease in PDH activity with fasting was blunted in the
ShcKO mice resulting in higher activities in these animals com-
pared to WT in the fasted state. Acetyl-CoA and NADH, products ofthe reaction, inﬂuence the activity of PDH through feedback in-
hibition. However, these metabolites are also produced by in-
creased β-oxidation [9], and also allosterically activate PDK which
in turn phosphorylates and inhibits PDH, as seen in this study.
Thus, PDH activity is inﬂuenced by both metabolites and phos-
phorylation through PDK. In the present study, the fed state de-
crease in PDH activity in the ShcKO versus WT mice was not due to
PDK since pPDH levels were not different between genotypes. The
decrease in fed state PDH activity in the ShcKO liver was likely due
to post-translational modiﬁcations other than phosphorylation
with metabolite inhibition (acetyl-CoA and NADH) possibly further
contributing to changes in enzyme activity in vivo. With fasting,
decreases in PDH activity in both genotypes match PDK4 and
pPDH levels. Therefore, differences in PDH activity between gen-
otypes during fasting appear to be due primarily to lower PDK4
levels in the ShcKO liver. The blunted decrease in PDH activity
with fasting in the ShcKO animals likely reﬂects the fact that
gluconeogenesis is increased in these mice and the decrease in
PDH activity needs to be limited to allow for entry of lactate and
amino acids into gluconeogenesis.
The activities of gluconeogenic enzymes and metabolite levels
provide further support for the idea that gluconeogenesis is in-
creased in liver from ShcKO versus WT mice. PEPCK is the rate
limiting enzyme in the gluconeogenic pathway and its activity is
increased in fasted ShcKO compared to WT animals. PEPCK is not
regulated allosterically or by phosphorylation/dephosphorylation
[36]. Nutrients, such as glucose and amino acids, indirectly reg-
ulate PEPCK activity by inﬂuencing acetylation of the enzyme [20].
In particular, amino acids diminish acetylation and render the
protein more stable and resistant to ubiquitin-mediated degrada-
tion [21], such as during fasting when gluconeogenesis is needed.
Alterations in activity of PEPCK in ShcKO liver do not appear to be
due to increases in level of PEPCK protein and additional studies
are needed to determine if Shc may inﬂuence PEPCK activity
through post-transitional modiﬁcations. Further support for an
increase in gluconeogenesis in the ShcKO mice is provided by the
ratios of gluconeogenic to glycolytic enzyme activities. Higher ra-
tios of PEPCK/PK, FBPase/PFK1 and G6Pase/GK provide an indica-
tion of increased gluconeogenic activity [23], and each of these
ratios were increased in ShcKO compared to WT mice. Shifts in
regulatory metabolite levels under fasting conditions were also
consistent with increased gluconeogenic enzyme activities in the
ShcKO animals. In particular, α-KG has been reported to be an
inhibitor of PEPCK [37] and F1P is an inhibitor of G6Pase [38], and
the levels of each of these inhibitory metabolites are decreased in
liver from fasted ShcKO compared to WT mice. Thus, PEPCK ac-
tivity, enzyme activity ratios and metabolite levels are consistent
with an increase in gluconeogenesis in ShcKO liver.
The present study also found some evidence of changes in
amino acid and lipid metabolism in the ShcKO mice. Consistent
with increased use of amino acids for gluconeogenesis, the activ-
ities of tryptophan and tyrosine transaminase were increased in
ShcKO compared to WT livers. Similar to our previous study which
indicated increased ketogenesis in the ShcKO mice [9], total ketone
body levels were higher in ShcKO compared to WT liver. This is
likely a consequence of the higher β-oxidation of fatty acids as
reported previously [9] that results in higher levels of acetyl-CoA.
These changes in metabolism are expected in an animal that has
shifted from glucose catabolism to gluconeogenesis and lipid
catabolism.
The transcription factors, AMPK and FOXO1, which play a role
in transitioning metabolism toward gluconeogenesis and fatty acid
metabolism were studied to see if they contributed to the changes
in metabolism observed in the ShcKO mice. The present study
does not ﬁnd evidence that FOXO1 is contributing to the differ-
ences in metabolism between the ShcKO and WT mice, since
Fig. 9. Schematic representation of the role of AMPK in the regulation of various
pathways in WT (A) and ShcKO (B) mice in the fasted state. Up (green) and down
(red) arrows indicate increased or decreased activities, respectively, of a given
pathway/enzyme/metabolite when compared with their corresponding fed state.
Thickness of the up or down arrows indicates the difference in the magnitude of
increased or decreased activities in the fasted state when comparison is made
between the fasted WT and ShcKO mice.
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it is possible that AMPK contributes to changes in metabolism
observed in the ShcKO versus WT mice. AMPK is considered the
major cellular energy sensor that is activated under conditions of
metabolic/oxidative stress and nutritional deprivation and phos-
phorylated AMPK (pAMPK, activated) inhibits pathways that
consume ATP, such as sterol and fatty acid synthesis, and activates
pathways such as fatty acid oxidation that generate ATP [39,40].
The role AMPK plays in the regulation of the various metabolic
pathways investigated in the present study are summarized in
Fig. 9. Activation of AMPK has been shown to suppress lipogenesis
[41], inhibit pyruvate kinase and increase ketogenesis [42]. These
changes in metabolism with activation of AMPK are similar to the
shifts in metabolism observed in ShcKO mice. Interestingly, gly-
cogen has also been reported to bind to AMPK and inhibit its ac-
tion, therefore, playing a role in its regulation [43–46]. The lower
glycogen levels observed in this study in the fasting state may
contribute to the activation of AMPK, speciﬁcally in the ShcKO
mice. The display of higher pAMPK levels in the ShcKO versus WT
mice under fasting conditions could contribute to shifts in meta-
bolism in ShcKO mice. However, it remains to be determined how
lower Shc protein levels are linked to phosphorylation of AMPK.
At the present stage of study, it is not possible to determine
which speciﬁc Shc protein is responsible for the observed changes
in metabolism since all three Shc proteins are decreased in livers
from the ShcKO mouse. However, the current study demonstrates
the important role Shc proteins play in metabolism, and future
development of mouse models with controlled expression of in-
dividual Shc proteins will be needed to determine the role each
Shc isoform plays in metabolism. Moreover, future work is needed
to determine the rates of glycolysis and gluconeogenesis so as to
establish ﬂux through these two critical pathways under various
nutritional conditions.
The results of the study show that decreased levels of Shc
proteins lead to a shift in liver metabolism toward decreasedglycolysis and increased gluconeogenesis and lipid metabolism.
This result expands previous work demonstrating decreased gly-
colytic enzyme activity in skeletal muscle [8] and increased ac-
tivities of enzymes involved in fatty acid and ketone body meta-
bolism in liver and skeletal muscle [9] from ShcKO compared to
WT mice, and indicates that Shc proteins should be considered as
regulators of fuel selection.Acknowledgments
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